Quarterly Report III 14/15
September 2014 – May 2015, Diamyd Medical AB (publ), Fiscal year 2014/2015Reporting period, March 1, 2015 – May 31, 2015 · Net result amounted to MSEK -7.3 (-3.6) · Net result per share amounted to SEK -0.4 (-0.2) · Cash flow from operating activities amounted to MSEK -4.8 (-4.1) · Liquid assets and short term investments amounted at the end of the period to MSEK 34.2 (38.8) First nine months, September 1, 2014 – May 31, 2015 · Net result amounted to MSEK -17.2 (-12.8) · Result per share amounted to SEK -0.9 (-0.6) · Cash flow from operating activities amounted